| Wang, Hui |
APPROACH, NCT04841811: MRD Guiding Treatment After Almonertinib Induction Therapy for EGFRm+ Stage III NSCLC in the MDT Diagnostic Model. |
|
|
| Recruiting | 3 | 192 | RoW | Almonertinib, ctDNA dynamic monitoring guided the Almonertinib treatment | Guangdong Association of Clinical Trials, Jiangsu Hansoh Pharmaceutical Co., Ltd. | Lung Cancer | 12/24 | 12/26 | | |
| Recruiting | 3 | 315 | RoW | TQB2450, Anlotinib, TQB2450(blank), Anlotinib(blank) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Stage III Non-small-cell Lung Cancer | 12/22 | 03/25 | | |
| Not yet recruiting | 3 | 358 | RoW | TQB2450+Anlotinib, TQB2450 placebo + Anlotinib placebo | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Small Cell Lung Cancer Limited Stage | 09/26 | 09/26 | | |
NCT06000956: A Study of Comparing Overall Improvement of Patients With Spondyloarthritis Treated With Jitongning Tablets and Placebo |
|
|
| Recruiting | 3 | 408 | RoW | Jitongning tablets, a simulated agent of Jitongning tablets | Tasly Pharmaceutical Group Co., Ltd | Ankylosing Spondylitis | 12/26 | 12/26 | | |
NCT05652894: A Study of HX008 Compared to Chemotherapy in the First-Line Treatment of Subjects With MSI-H/dMMR Metastatic Colorectal Cancer |
|
|
| Not yet recruiting | 3 | 190 | RoW | HX008, Investigator's Choice Chemotherapy | Taizhou Hanzhong biomedical co. LTD | Metastatic Colorectal Cancer | 01/26 | 10/28 | | |
NCT05254665: A Study of Docetaxel Polymeric Micelles for Injection in Patients With Advanced Solid Tumors |
|
|
| Not yet recruiting | 2 | 110 | RoW | Docetaxel Polymeric Micelles for Injection | Jiangsu Simcere Pharmaceutical Co., Ltd. | Advanced Solid Tumors | 12/22 | 03/24 | | |
NCT04922450: Clinical Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy for Operable Locally Advanced Head and Neck Squamous Cell Carcinoma |
|
|
| Recruiting | 2 | 53 | RoW | PD-1 inhibitor, Albumin Paclitaxel, Cisplatin | Hunan Cancer Hospital, Jiangsu HengRui Medicine Co., Ltd. | Head and Neck Cancer, Squamous Cell Carcinoma | 01/23 | 01/23 | | |
NCT05815862: Clinical Study of AL2846 Capsules in the Treatment of Advanced Lung Tumor and Advanced Ovarian Cancer |
|
|
| Recruiting | 2 | 40 | RoW | AL2846 capsule | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Advanced Lung Cancer, Ovarian Cancer | 06/24 | 12/24 | | |
SKB264-II-04, NCT05816252: A Study of SKB264 for the Treatment of Participants With Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) |
|
|
| Recruiting | 2 | 498 | Europe, RoW | SKB264, MK-2870, Pembrolizumab, MK-3475, Carboplatin, Carboplatin for injection, Osimertinib, Osimertinib Mesylate | Klus Pharma Inc., Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Non-small Cell Lung Cancer | 12/25 | 10/26 | | |
AK104-IIT-024, NCT05824494: Cadonilimab Plus Nab -Paclitaxel for Patients With Recurrent, or Metastatic Cervical Cancer Resistant to Immune Checkpoint Inhibitors |
|
|
| Not yet recruiting | 2 | 58 | NA | Cadonilimab, Nab paclitaxel | Women's Hospital School Of Medicine Zhejiang University, Akeso | Uterine Cervical Neoplasms, Cancer of Cervix, Cervical Cancer, Cervical Neoplasms, Uterine Cervical Cancer, Cancer of the Uterine Cervix | 06/26 | 06/26 | | |
NCT05794477: A Study of SHR-1802 in Combination With Adebrelimab in Patients With Advanced Solid Tumors |
|
|
| Recruiting | 1/2 | 132 | RoW | Adebrelimab, SHR-1802, Carboplatin/Cisplatin, Paclitaxel/Nab-Paclitaxel/Pemetrexed | Shanghai Hengrui Pharmaceutical Co., Ltd. | Advanced Solid Tumor | 07/25 | 12/25 | | |
| Active, not recruiting | 1 | 45 | RoW | ICVAX, Placebo | Immuno Cure Holding (HK) Limited, Shenzhen Third People's Hospital, Shenzhen Immuno Cure Biomedical Company Limited | Human Immunodeficiency Virus, Human Immunodeficiency Virus I Infection | 09/24 | 01/25 | | |
| Recruiting | 1 | 15 | RoW | Autologous tumor-infiltrating lymphocyte cells | Hervor Therapeutics, Jinling Hospital, China, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Women's Hospital School Of Medicine Zhejiang University | Advanced Solid Tumor | 12/25 | 12/26 | | |
NCT05606848: To Test the Food for Special Medical Purpose in Perioperative Patients With Gastrointestinal Cancer |
|
|
| Recruiting | N/A | 350 | RoW | Nutrition Emulsion (TPF-T), Foods for special medical purposes [FSMP] for patients with tumors | Fresenius Kabi Sino-Swed Pharmaceutical Corp. Ltd | Gastrointestinal Cancer | 03/25 | 03/25 | | |
